STOCK TITAN

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Twist Bioscience (NASDAQ: TWST) will report its fiscal 2024 second-quarter financial results on May 2, 2024, after the market closes. The company will host a conference call at 4:30 p.m. ET to discuss the results and provide a business update. The press release and webcast will be accessible on the company's website. Telephone participants can register on the Investor Relations website to receive the dial-in number and unique PIN for access.
Twist Bioscience (NASDAQ: TWST) comunicherà i risultati finanziari del secondo trimestre dell'anno fiscale 2024 il 2 maggio 2024, dopo la chiusura del mercato. La società terrà una conferenza telefonica alle 16:30 ET per discutere i risultati e fornire un aggiornamento sulle attività aziendali. Il comunicato stampa e la webcast saranno disponibili sul sito web della compagnia. I partecipanti via telefono possono registrarsi sul sito delle Relazioni con gli Investitori per ricevere il numero di accesso e il PIN unico necessari.
Twist Bioscience (NASDAQ: TWST) informará sobre sus resultados financieros del segundo trimestre del año fiscal 2024 el 2 de mayo de 2024, después del cierre del mercado. La empresa realizará una llamada de conferencia a las 4:30 p.m. ET para discutir los resultados y proporcionar una actualización sobre el negocio. El comunicado de prensa y la transmisión web estarán disponibles en el sitio web de la compañía. Los participantes telefónicos pueden registrarse en el sitio web de Relaciones con Inversores para recibir el número de marcado y el PIN único para el acceso.
Twist Bioscience (NASDAQ: TWST)는 2024년 5월 2일 시장 마감 후 2024 회계연도 두 번째 분기 재무 결과를 보고할 예정입니다. 회사는 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 주최할 것입니다. 보도 자료 및 웹캐스트는 회사 웹사이트에서 접근할 수 있습니다. 전화 참가자들은 투자자 관계 웹사이트에서 등록하여 접속 번호와 고유 PIN을 받을 수 있습니다.
Twist Bioscience (NASDAQ: TWST) publiera ses résultats financiers pour le deuxième trimestre de l'exercice 2024 le 2 mai 2024, après la fermeture du marché. La société organisera une conférence téléphonique à 16h30 HE pour discuter des résultats et fournir une mise à jour des activités. Le communiqué de presse et la webdiffusion seront accessibles sur le site web de l'entreprise. Les participants par téléphone peuvent s'inscrire sur le site des Relations Investisseurs pour obtenir le numéro d'appel et un PIN unique pour l'accès.
Twist Bioscience (NASDAQ: TWST) wird am 2. Mai 2024 nach Börsenschluss die Finanzergebnisse des zweiten Quartals des Geschäftsjahres 2024 bekannt geben. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben. Die Pressemitteilung und die Webübertragung werden auf der Website des Unternehmens zugänglich sein. Telefonische Teilnehmer können sich auf der Investor Relations Website registrieren, um die Einwahlnummer und eine einzigartige PIN für den Zugang zu erhalten.
Positive
  • None.
Negative
  • None.

Company to host conference call at 4:30 p.m. ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024, after market close on Thursday, May 2, 2024. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com.

The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on LinkedIn | X | YouTube | Instagram

For Investors:

Angela Bitting

SVP, Corporate Affairs

925-202-6211

abitting@twistbioscience.com

For Media:

Amanda Houlihan

Communications Manager

774-265-5334

ahoulihan@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

When will Twist Bioscience report its fiscal 2024 second-quarter financial results?

Twist Bioscience will report its fiscal 2024 second-quarter financial results on Thursday, May 2, 2024, after the market closes.

What time will the conference call to discuss the financial results take place?

The conference call to discuss the financial results will take place at 4:30 p.m. Eastern Time.

Where can I access the press release with the financial results?

The press release with the financial results will be accessible on Twist Bioscience 's website under the Investor Relations section.

How can I participate in the conference call via telephone?

To participate in the conference call via telephone, you must register on the Company's Investor Relations website to receive the dial-in number and unique PIN for access.

How long will the webcast replay be available?

The webcast replay will be available for two weeks.

Twist Bioscience Corporation

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Stock Data

1.85B
56.87M
1.78%
113.36%
21.2%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
SOUTH SAN FRANCISCO

About TWST

at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .